GlassScriptPhysician profile
Nevan G Baldwin
NPI 1043262363
$214,009.95
in general payments reported to CMS, 2019-2025
9 companies · $1,349 in 2025
The $1,349 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $61K · 2021: $35K · 2022: $41K · 2023: $12K · 2024: $8,009 · 2025: $1,349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $20K · Travel and Lodging: $997 · Food and Beverage: $534.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $19,513.47 |
| Travel and Lodging | $997.44 |
| Food and Beverage | $534.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $176,533.00 | 2019-2023 | Archon, Acp |
| Medtronic, INC. | $27,592.00 | 2021-2025 | Mazor X System, Anteralign Spinal System With Titan Nanolock Surface Technology, Stealthstation S8 Platform |
| Globus Medical, INC. | $8,133.52 | 2020-2024 | Archon |
| Stryker Corporation | $1,119.07 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $250.00 | 2019 | |
| Depuy Synthes Sales INC. | $172.92 | 2019 | |
| Centinel Spine, LLC | $134.65 | 2020 | |
| Abbott Laboratories | $51.29 | 2023-2024 | Proclaim |
| Boston Scientific Corporation | $23.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nevan Baldwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.